{"id":"https://openalex.org/W2007283066","doi":"https://doi.org/10.2146/ajhp070685","title":"Use of controller medications in patients initiated on a long-acting \u03b22-adrenergic agonist before and after safety alerts","display_name":"Use of controller medications in patients initiated on a long-acting \u03b22-adrenergic agonist before and after safety alerts","publication_year":2008,"publication_date":"2008-08-07","ids":{"openalex":"https://openalex.org/W2007283066","doi":"https://doi.org/10.2146/ajhp070685","mag":"2007283066","pmid":"https://pubmed.ncbi.nlm.nih.gov/18693208"},"language":"en","primary_location":{"id":"doi:10.2146/ajhp070685","doi":"https://doi.org/10.2146/ajhp070685","is_oa":false,"landing_page_url":"https://doi.org/10.2146/ajhp070685","pdf_url":null,"source":{"id":"https://openalex.org/S105051383","display_name":"American Journal of Health-System Pharmacy","issn_l":"1079-2082","issn":["1079-2082","1535-2900"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Health-System Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078972744","display_name":"Karen M. Stockl","orcid":"https://orcid.org/0009-0007-9912-0211","observed_orcids":["https://orcid.org/0009-0007-9912-0211"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Karen M. Stockl","raw_affiliation_strings":["Biostatistics, Prescription Solutions, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Prescription Solutions, Irvine, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071526496","display_name":"Lisa W. Le","orcid":"https://orcid.org/0000-0002-0084-9915","observed_orcids":["https://orcid.org/0000-0002-0084-9915"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Le","raw_affiliation_strings":["Biostatistics, Prescription Solutions, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Prescription Solutions, Irvine, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035118554","display_name":"Ann S. M. Harada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann S. M. Harada","raw_affiliation_strings":["Biostatistics, Prescription Solutions, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Prescription Solutions, Irvine, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082026809","display_name":"Shaoang Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaoang Zhang","raw_affiliation_strings":["Biostatistics, Prescription Solutions, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Prescription Solutions, Irvine, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5078972744"],"corresponding_institution_ids":[],"apc_list":{"value":4448,"currency":"USD","value_usd":4448},"apc_paid":null,"fwci":0.8609,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.77951602,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"65","issue":"16","first_page":"1533","last_page":"1538"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.7534000277519226,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.7534000277519226,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.10729999840259552,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.07029999792575836,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/long-acting-beta-agonists","display_name":"long-acting beta2-agonists","score":0.9879999756813049},{"id":"https://openalex.org/keywords/controller-medications","display_name":"controller medications","score":0.9049999713897705},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.6650000214576721},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/fda-safety-alert","display_name":"FDA safety alert","score":0.7279999852180481},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.972000002861023},{"id":"https://openalex.org/keywords/mast-cell-stabilizers","display_name":"mast cell stabilizers","score":0.8679999709129333},{"id":"https://openalex.org/keywords/theophylline","display_name":"theophylline","score":0.9679999947547913},{"id":"https://openalex.org/keywords/leukotriene-modifiers","display_name":"leukotriene modifiers","score":0.9789999723434448},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.7540000081062317},{"id":"https://openalex.org/keywords/medication-utilization","display_name":"medication utilization","score":0.5080000162124634},{"id":"https://openalex.org/keywords/drug-safety-warnings","display_name":"drug safety warnings","score":0.40400001406669617}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7155356407165527},{"id":"https://openalex.org/C158453852","wikidata":"https://www.wikidata.org/wiki/Q4684738","display_name":"Adrenergic","level":3,"score":0.6846739053726196},{"id":"https://openalex.org/C2780013391","wikidata":"https://www.wikidata.org/wiki/Q2496749","display_name":"Adrenergic agonist","level":4,"score":0.5690003633499146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5042122602462769},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42810288071632385},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3478613495826721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1842862069606781},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07675212621688843}],"mesh":[{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004348","descriptor_name":"Drug Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007345","descriptor_name":"Insurance Claim Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2146/ajhp070685","doi":"https://doi.org/10.2146/ajhp070685","is_oa":false,"landing_page_url":"https://doi.org/10.2146/ajhp070685","pdf_url":null,"source":{"id":"https://openalex.org/S105051383","display_name":"American Journal of Health-System Pharmacy","issn_l":"1079-2082","issn":["1079-2082","1535-2900"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Health-System Pharmacy","raw_type":"journal-article"},{"id":"pmid:18693208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18693208","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1992927302","https://openalex.org/W2000445173","https://openalex.org/W2129168200","https://openalex.org/W2142724633","https://openalex.org/W2163441905","https://openalex.org/W2322498581","https://openalex.org/W4241883193"],"related_works":["https://openalex.org/W2118773007","https://openalex.org/W2080654393","https://openalex.org/W2592610814","https://openalex.org/W2186267126","https://openalex.org/W7100286480","https://openalex.org/W2083038700","https://openalex.org/W2595411672","https://openalex.org/W2074610055","https://openalex.org/W2221937545","https://openalex.org/W2029973867"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1],"utilization":[2],"of":[3,130,140,206,212,219,225,237,242,247,260,273],"controller":[4,91,132,208,249],"medications":[5],"before":[6,13,44,86,121,133,176,210],"initiating":[7],"a":[8,29,96,131,207,223,248],"long-acting":[9],"beta(2)-adrenergic":[10],"agonist":[11],"(LABA)":[12],"and":[14,18,54,78,124,158,190,233,235],"after":[15,55,126,170],"the":[16,33,82,87,113,122,127,270],"Food":[17],"Drug":[19],"Administration":[20],"(FDA)":[21],"alerts":[22,46,57,123,172,178,265],"is":[23],"examined.":[24],"METHODS:":[25],"Electronic":[26],"claims":[27],"from":[28],"health":[30],"insurer":[31],"in":[32,138,217,253,276],"Western":[34],"United":[35],"States":[36],"were":[37,67,119],"examined":[38],"during":[39,81,112],"two":[40],"distinct":[41],"identification":[42,88],"periods:":[43],"FDA":[45,56,171,177,268],"(October":[47],"1,":[48,59],"2003,":[49],"through":[50,61],"September":[51,62],"30,":[52,63],"2005)":[53],"(December":[58],"2005,":[60],"2006).":[64],"Identified":[65],"patients":[66,118,141,180,191,221,238,254,277],"at":[68],"least":[69],"12":[70],"years":[71],"old,":[72],"newly":[73],"initiated":[74],"on":[75],"an":[76,99,134,213],"LABA,":[77],"continuously":[79],"enrolled":[80],"preperiod":[83],"(six":[84],"months":[85],"date).":[89],"Previous":[90,204],"use":[92,167,205],"was":[93,136,215],"defined":[94],"as":[95,173],"prescription":[97],"for":[98,179],"inhaled":[100],"corticosteroid,":[101],"mast-cell":[102],"stabilizer,":[103],"theophylline,":[104],"leukotriene":[105],"modifier,":[106],"or":[107,109,163,195,244,257,262],"oral":[108],"injectable":[110],"corticosteroid":[111],"preperiod.":[114],"RESULTS:":[115],"Overall,":[116],"18,115":[117],"identified":[120],"7,347":[125],"alerts.":[128],"Use":[129,246],"LABA":[135,214],"observed":[137,216],"40%":[139,218],"with":[142,146,154,160,175,181,192,222,228,231,239,255],"asthma":[143,162,182,194,243,256,261],"only,":[144,152],"37%":[145,227],"chronic":[147],"obstructive":[148],"pulmonary":[149],"disease":[150],"(COPD)":[151],"65%":[153,230],"COPD":[155,164,196,232,263],"plus":[156],"asthma,":[157,226,234],"21%":[159,236],"no":[161,193,240,258],"diagnosis.":[165],"Controller":[166],"decreased":[168,251],"significantly":[169,252],"compared":[174],"only":[183],"(38%":[184],"versus":[185,198],"41%,":[186],"p":[187,200],"=":[188],"0.005)":[189],"(17%":[197],"23%,":[199],"<":[201],"0.0001).":[202],"CONCLUSION:":[203],"medication":[209,250],"initiation":[211],"study":[220],"diagnosis":[224,241,259],"COPD,":[229],"COPD.":[245],"following":[264],"issued":[266],"by":[267],"regarding":[269],"increased":[271],"risk":[272],"asthma-related":[274],"death":[275],"receiving":[278],"LABAs.":[279]},"counts_by_year":[{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}